ERBB3 and lung adenocarcinoma: ERBB3-BCAR4 fusion has been reported in two patients: one patient from the lung adenocarcinoma project of the Cancer Genome Atlas consortium (TCGA-LUAD) and another from a whole-genome sequencing study of Chinese lung adenocarcinoma (Cancer Genome Atlas Research, 2014; Wu et al., 2015).